Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization
about
Molecular diagnosis in autoimmune skin blistering conditionsMucous membrane pemphigoidImmunopathology and molecular diagnosis of autoimmune bullous diseasesAdhesion receptors in health and disease.Expression of selected integrins and selectins in bullous pemphigoid.Mucosal disease series. Number III. Mucous membrane pemphigoid.Mechanisms of blister induction by autoantibodies.Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.Pemphigoid diseases: pathogenesis, diagnosis, and treatment.Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management.Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction.Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm.Outcomes of cataract surgery in ocular cicatricial pemphigoid.Autoantibodies to human alpha6 integrin in patients with oral pemphigoid.Treatment strategies in mucous membrane pemphigoid.Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report.Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity.Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.Salivary IgA and IgG antibodies to bullous pemphigoid 180 noncollagenous domain 16a as diagnostic biomarkers in mucous membrane pemphigoid.Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid.
P2860
Q27025483-A68B890C-972E-4D4A-B27F-138073A1D0F5Q27691456-8F65F583-8228-42C2-A41E-C04010DFB1A5Q28303627-36259F6D-F066-488C-BF88-A835817994A8Q33888277-AB7245E3-545C-4EA9-BEFF-FD9058C10C25Q35791244-2692C3A0-D7ED-45C7-A3E0-0FB34EAD7C0DQ36177681-C49445B9-801B-4039-9BAE-4CB1C5E4DCA6Q36307954-655E3132-608A-497B-8C50-3243EB429EECQ36699586-75AF4AD9-7B04-479A-BF68-EDEDF4D3F776Q37933427-23B4DC0E-C8E6-4F47-822C-2E3D18EC4CEBQ37940584-E3785CE6-0E23-419D-94C6-C636B78F28A5Q38287144-B0433288-B835-4DE7-98D3-65E3BB9B1866Q38812302-430BA0F6-6FF5-4314-86D5-D67E16B01239Q39367693-96FF716C-3FA6-43DD-8E2A-E7E1D44A3AF8Q40773305-FF9372D0-921D-4BF2-99AF-D02D181CA77EQ41359384-8354FAB4-AB3E-4585-B71D-A8B20786376BQ41879035-51AC2D35-3E63-4830-827A-DB90EAEE0B10Q42525239-1A26D814-18FF-4073-A01F-E1FDEC283505Q42665116-095D9142-F6AB-4F2E-A206-BC9569845492Q44094923-38BA834B-8B88-4137-8B5B-5D68E88A97A3Q48279461-161E79DB-68CB-40EE-B01D-4C7B7ECFD9BFQ50771840-CFCF5263-A2AF-4D4B-9633-D84846B2D9E0Q55510483-D6A68E0F-FBC2-44D2-A907-03491D6EF847
P2860
Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization
@en
type
label
Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization
@en
prefLabel
Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization
@en
P2093
P2860
P356
P1476
Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization
@en
P2093
C Livir-Rallatos
C S Foster
K Natarajan
P2860
P304
14714-14719
P356
10.1073/PNAS.93.25.14714
P407
P577
1996-12-01T00:00:00Z